Article
Vascular complications in NPM1-Mutated acute myeloid leukemia: clinical features and prognosis.
Annals of hematology - 20 Jan 2026
Wang Xiaoying, Mo Wenbin, Chen Miao, Sui Jingchen, Bian Renjie, Yan Xiaojing
Abstract excerpt
Although nucleophosmin 1 (NPM1) mutation is generally considered a favorable prognostic biomarker in acute myeloid leukemia (AML), its clinical behavior is heterogeneous. A subset of NPM1-mutated patients continues to experience adverse outcomes despite their favorable genotype. We conducted a retrospective analysis of newly diagnosed NPM1-mutated AML patients treated at The First Affiliated Hospital of China...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
